Adverum Biotechnologies is a clinical-stage gene therapy company dedicated to addressing unmet medical needs in ophthalmology and rare diseases. The organization is working on developing gene therapy product candidates aiming for durable efficacy through sustained expression of therapeutic proteins. Adverum's core capabilities encompass clinical development, novel vector discovery, and in-house manufacturing expertise, emphasizing scalable process development and compliance with current Good Manufacturing Practices (cGMP) quality control. A central tenet of Adverum’s culture is its commitment to inclusion and diversity, fostering an environment where all employees feel empowered to express their authentic selves, share knowledge, and grow professionally, regardless of their backgrounds. This focus not only enhances the company's collaborative spirit but also drives innovation and excellence in their mission to improve patient outcomes.